Annual report pursuant to Section 13 and 15(d)

SEGMENT REPORTING - Concentration Risk (Details)

v3.22.1
SEGMENT REPORTING - Concentration Risk (Details) - Customer Concentration Risk
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue Benchmark | Non-Cannabinoid | Customer C    
Segment Reporting Information [Line Items]    
Concentration risk, percentage 17.00% 21.00%
Accounts Receivable | Cannabinoid | Customer A    
Segment Reporting Information [Line Items]    
Concentration risk, percentage   40.00%
Accounts Receivable | Cannabinoid | Customer B    
Segment Reporting Information [Line Items]    
Concentration risk, percentage   23.00%
Accounts Receivable | Cannabinoid | Customer D    
Segment Reporting Information [Line Items]    
Concentration risk, percentage 18.00%  
Accounts Receivable | Non-Cannabinoid | Customer C    
Segment Reporting Information [Line Items]    
Concentration risk, percentage 25.00% 11.00%